Evidence map›Paper›PMID 42290881›Full record

ArticleCase reports in hematology2026

A Rare Case of Neonatal Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon Presenting as an Abdominal Mass Without Cutaneous Manifestations.

Su Young Park, Amrryn Halari, Jessenia Palacio-Meadows, Nehal S Parikh, Danielle Bentsen, Surasak Puvabanditsin

Abstract read
In one paragraph

Article in Case reports in hematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Su Young ParkRutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA, rutgers.edu.ORCID https://orcid.org/0009-0001-5995-9123
Amrryn HalariRutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA, rutgers.edu.ORCID https://orcid.org/0009-0004-6791-121X
Jessenia Palacio-MeadowsRutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA, rutgers.edu.ORCID https://orcid.org/0009-0002-2520-5988
Nehal S ParikhRutgers Cancer Institute, New Brunswick, New Jersey, USA.ORCID https://orcid.org/0000-0002-4746-1168
Danielle BentsenRutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA, rutgers.edu.ORCID https://orcid.org/0009-0003-2212-1487
Surasak PuvabanditsinRutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA, rutgers.edu.ORCID https://orcid.org/0000-0002-7467-5874

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kaposiform hemangioendothelioma (KHE) is a rare vascular neoplasm that typically presents in infancy or early childhood, classified as a locally aggressive/borderline vascular tumor. It most commonly involves superficial and deep soft tissues, often demonstrating infiltrative growth into adjacent muscle and bone, whereas retroperitoneal or intraabdominal presentations are less frequent. KHE is frequently complicated by Kasabach-Merritt phenomenon (KMP), a severe consumptive coagulopathy characterized by profound thrombocytopenia, microangiopathic hemolytic anemia, and hypofibrinogenemia with life-threatening sequelae. We report a case of a male neonate who developed KMP secondary to an abdominal KHE without overlying cutaneous involvement. Diagnosis was established through integration of clinical features, imaging findings, hematological evaluation, and confirmatory biopsy. This patient was managed with a multimodal regimen of sirolimus, corticosteroids, and vincristine, resulting in significant clinical improvement. This case underscores both the diagnostic complexity and therapeutic challenges of KHE complicated by KMP, particularly when lesions occur in deep anatomical sites. Given the rarity of this condition, current management strategies rely largely on expert consensus and case-based experience, though recent randomized trial and consensus have established sirolimus-based regimens as highly effective first-line therapy.

Identifiers

PMID42290881
PMCPMC13263245

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.